CINECA IRIS Institutional Research Information System

GIRAUDO, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.969
EU - Europa 3.496
AS - Asia 2.433
AF - Africa 67
OC - Oceania 28
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 11
Totale 11.031
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.879
CN - Cina 1.312
IT - Italia 1.122
SG - Singapore 383
DE - Germania 336
IE - Irlanda 318
FR - Francia 277
SE - Svezia 271
GB - Regno Unito 234
FI - Finlandia 180
UA - Ucraina 177
JP - Giappone 149
AT - Austria 126
KR - Corea 123
DK - Danimarca 102
PL - Polonia 88
VN - Vietnam 81
CA - Canada 80
HK - Hong Kong 80
IN - India 71
BE - Belgio 51
NL - Olanda 46
ID - Indonesia 44
SN - Senegal 44
TW - Taiwan 41
ES - Italia 39
IL - Israele 35
CH - Svizzera 34
AU - Australia 25
TR - Turchia 24
IR - Iran 23
RU - Federazione Russa 22
BR - Brasile 14
RO - Romania 14
TH - Thailandia 14
PK - Pakistan 13
HU - Ungheria 12
ZA - Sudafrica 12
GR - Grecia 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
MX - Messico 9
SA - Arabia Saudita 7
AR - Argentina 6
LT - Lituania 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
CO - Colombia 4
HR - Croazia 4
NO - Norvegia 4
AM - Armenia 3
CI - Costa d'Avorio 3
CL - Cile 3
EG - Egitto 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
DZ - Algeria 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
RS - Serbia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
JO - Giordania 1
MA - Marocco 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 11.031
Salva come PNG Salva come JPEG
Città #
Chandler 501
Beijing 388
Ann Arbor 359
Santa Clara 326
Dublin 315
Torino 295
Singapore 292
Fairfield 259
Houston 223
Ashburn 174
Woodbridge 151
Dearborn 147
Jacksonville 146
Seattle 137
Wilmington 135
Villeurbanne 129
Vienna 120
Nyköping 113
Shanghai 108
Cambridge 105
Redwood City 103
Guangzhou 98
Princeton 95
Medford 91
Columbus 88
Milan 88
Pisa 81
Hangzhou 64
Warsaw 62
Nanjing 61
Fremont 55
Turin 55
Dong Ket 46
Boston 44
Jakarta 43
Tokyo 40
Helsinki 38
Wuhan 36
Brussels 34
Rome 33
Los Angeles 31
Taipei 29
Jinan 28
Boardman 27
San Diego 27
London 26
Hefei 22
Changsha 20
Chengdu 20
Frankfurt am Main 20
New York 20
Ottawa 18
San Francisco 18
Central 17
Xian 17
Norwalk 16
Paris 16
Menlo Park 15
Munich 15
Phoenix 15
Zhengzhou 15
Chongqing 14
Falls Church 14
Dallas 13
Tianjin 13
Toronto 13
Viterbo 13
Central District 12
Fuzhou 12
Hebei 12
Silver Spring 12
Verona 12
Herzliya 11
Hong Kong 11
Kunming 11
Chicago 10
Moscow 10
New Haven 10
Rehovot 10
Barcelona 9
Bethesda 9
Istanbul 9
Lanzhou 9
Leiden 9
Luni 9
Nanchang 9
Philadelphia 9
Simi Valley 9
Trieste 9
Birmingham 8
Cincinnati 8
Duncan 8
Naples 8
Pittsburgh 8
Sassari 8
Shenzhen 8
Zurich 8
Amsterdam 7
Bari 7
Créteil 7
Totale 6.498
Salva come PNG Salva come JPEG
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.940
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 656
PROCEEDINGS OF THE MERCK & ELSEVIER YOUNG CHEMISTSSYMPOSIUM 299
Semaphorins in cardiovascular medicine. 295
Regulation of HMGCoA reductase Activity by Policosanol and Octacosadienol, a New synthetic Analogue of Octacosanol 279
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 247
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling 227
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. 205
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability. 200
NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE 199
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 196
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 187
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 180
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis 170
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation 162
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance 162
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 158
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. 152
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers 150
Class 3 semaphorins in cardiovascular development 140
The role of semaphorins and their receptors in vascular development and cancer 136
Effect of inhibiting the sterol biosynthesis pathway and the cholesterol content in the regulation of angiogenesis in vitro and in vivo 126
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth 121
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 120
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors 119
Biological aspects of tumour angiogenesis 117
Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. 112
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 111
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 109
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 106
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety 105
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 99
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 98
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 95
Medical use of combinations of non-natural semaphorins 3 and antimetabolites 94
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 93
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 90
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 90
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. 85
Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors 84
Semaphorins and tumor angiogenesis 81
Class 3 semaphorin in angiogenesis and lymphangiogenesis 79
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 78
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer 76
In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. 75
Increased Expression of {alpha}6 Integrin in Endothelial Cells Unveils a Proangiogenic Role for Basement Membrane 75
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 75
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 75
Zoledronic acid targets tumor-associated macrophages to overcome the resistance to the anti-angiogenic therapy in a mouse model of spontaneous cervical cancer 74
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models 74
A novel population of neuropilin-1-expressing mononuclear cells (NEMs) contributes to tumor vessel stabilization and normalization 72
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 71
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 70
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer 69
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 69
Modeling the early stages of vascular network assembly. 68
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy 67
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 66
Percolation, morphogenesis, and burgers dynamics in blood vessels formation. 65
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 65
Squalenic nanoparticles with active targeting: in vivo results 64
Zoledronic acid inhibit angiogenesis and impairs tumorigenesis in a mouse model of cervical carcinogenesis 64
IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells. 63
Tumor necrosis factor-a regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. 62
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis 61
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 59
A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers 58
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner 58
Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1. 56
Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA. 56
Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. 55
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 55
Targeted nanoparticles for pancreatic cancer. 53
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor 53
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma 52
The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. 51
Targeted nanoparticles for pancreatic cancer. 51
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition 51
Lymphatic zip codes in premalignant lesions and tumors 50
Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. 49
Nanoparticles targeting pancreatic tumor. 49
New human dihydroorotate dehydrogenase inhibitors able to restore myeloid differentiation in AML 44
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 41
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability 39
Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth 39
Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front 36
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression 29
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 27
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 27
PlexinB1 deficiency in the microenvironment inhibits tumor growth and metastatic dissemination in mouse models of triple negative breast cancer 26
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 23
PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination 22
Breast cancers as ecosystems: a metabolic perspective 22
Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer 18
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 12
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 11
Totale 11.344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.723
article - articoli 0
book - libri 0
conference - conferenze 8.781
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020944 0 0 0 0 0 221 145 117 146 132 104 79
2020/20211.495 95 81 76 97 183 117 124 74 156 148 152 192
2021/20221.628 118 105 102 124 98 115 96 103 90 132 311 234
2022/20231.845 159 170 64 163 161 403 163 121 175 70 120 76
2023/20241.255 123 176 94 115 99 92 87 95 27 88 109 150
2024/20251.328 75 147 173 214 566 153 0 0 0 0 0 0
Totale 11.344